Page of

Screening for Cancer in Normal and At-Risk Populations 

Screening for Cancer in Normal and At-Risk Populations
Source:
Psycho-Oncology (3 ed.)

The goal of colorectal cancer (CRC) screening is to reduce morbidity and mortality from CRC, the second leading cause of cancer deaths in the US. Regular screening with the fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy can reduce incidence and mortality from CRC. Organizations such as the American Cancer Society recommend that persons at average risk begin CRC screening at age 50. Recent data show that incidence and mortality from CRC has declined, in part, due to increased use of screening. Behavioral research to identify the determinants of screening and evaluate interventions to increase screening has contributed to improving screening rates. The cumulative evidence supports client reminders, small media, one-on-one education, reducing structural barriers, provider assessment and feedback, and provider reminder and recall systems as effective interventions for increasing CRC screening. Recent reviews of the CRC screening intervention literature have focused on minority populations, healthcare systems, and patient navigation.

Sign In

Copyright © 2021. All rights reserved.